FDG PET Assessment of Osteomyelitis: A Review.

This article discusses the role of [(18)F]Fluorodeoxyglucose (FDG) PET and PET/computed tomography in diagnosis and therapeutic response assessment for the management of patients with osteomyelitis, to increase awareness of imaging pitfalls and to improve understanding of specific technical and diagnostic challenges in patients with posttraumatic chronic osteomyelitis, spinal infections, prosthetic joint infections, and diabetic foot infections. This article focuses on the usefulness of modern imaging modalities in the setting of suspected infection or inflammation and on the role of FDG-PET in the management of patients with suspected or confirmed infection in the bones.